keyword
https://read.qxmd.com/read/38554268/occult-lung-cancer-associated-autoimmune-encephalitis-presenting-as-acute-psychosis
#21
JOURNAL ARTICLE
Shelly K McCarter, K Robert Shen, Mark E Wylam
During deployment, a 52-year-old male developed acute behavioral changes. Though initially considered to have PTSD and related agitation and confusional state, his evaluation was consistent with acute encephalopathy. Magnetic resonance imaging of the brain showed T2 hyperintensities, and CSF analysis was positive for anti-N-methyl-D-aspartate receptor antibody. A nuclear protein in testis carcinoma midline carcinoma was discovered in the lung. Immunotherapy and surgical resection led to steady improvement prior to adjuvant chemotherapy...
March 30, 2024: Military Medicine
https://read.qxmd.com/read/38551448/monitoring-ros-responsive-fe3o4-based-nanoparticle-mediated-ferroptosis-immunotherapy-via-129xe-mri
#22
JOURNAL ARTICLE
Lei Zhang, Maosong Qiu, Ruifang Wang, Sha Li, Xiaoxun Liu, Qiuyi Xu, Long Xiao, Zhong-Xing Jiang, Xin Zhou, Shizhen Chen
The immune checkpoint blockade strategy has improved the survival rate of late-stage lung cancer patients. However, the low immune response rate limits the immunotherapy efficiency. Here, we report a ROS-responsive Fe3O4-based nanoparticle that undergoes charge reversal and disassembly in the tumor microenvironment, enhancing the uptake of Fe3O4 by tumor cells and triggering a more severe ferroptosis. In the tumor microenvironment, the nanoparticle rapidly disassembles and releases the loaded GOx and the immune-activating peptide Tuftsin under overexpressed H2O2...
March 29, 2024: Angewandte Chemie
https://read.qxmd.com/read/38547669/visual-scoring-of-osteoporosis-on-low-dose-ct-in-lung-cancer-screening-population
#23
JOURNAL ARTICLE
Yeqing Zhu, Rowena Yip, Artit C Jirapatnakul, Mingqian Huang, Qiang Cai, Etan Dayan, Li Liu, Anthony P Reeves, Claudia I Henschke, David F Yankelevitz
OBJECTIVES: The risk factors for lung cancer screening eligibility, age as well as smoking history, are also present for osteoporosis. This study aims to develop a visual scoring system to identify osteoporosis that can be applied to low-dose CT scans obtained for lung cancer screening. MATERIALS AND METHODS: We retrospectively reviewed 1000 prospectively enrolled participants in the lung cancer screening program at the Mount Sinai Hospital. Optimal window width and level settings for the visual assessment were chosen based on a previously described approach...
February 29, 2024: Clinical Imaging
https://read.qxmd.com/read/38546390/tumor-microenvironment-landscapes-supporting-egfr-mutant-nsclc-are-modulated-at-the-single-cell-interaction-level-by-unesbulin-treatment
#24
JOURNAL ARTICLE
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, Valerie A Maymi, Nicole Pandell, Eva Csizmadia, Junyan Zhang, Marla Weetall, Art Branstrom, Giulia Braccini, Eva Cabrera San Millán, Barbara Storti, Ranieri Bizzarri, Olivier Kocher, Daniela S Daniela Sanchez Bassères, Robert S Welner, Maria Cristina Magli, Ivan Merelli, John G Clohessy, Azhar Ali, Daniel G Tenen, Elena Levantini
UNLABELLED: Lung cancer is the leading cause of cancer deaths. Lethal pulmonary adenocarcinomas (ADC) present with frequent mutations in the EGFR. Genetically engineered murine models of lung cancer expedited comprehension of the molecular mechanisms driving tumorigenesis and drug response. Here, we systematically analyzed the evolution of tumor heterogeneity in the context of dynamic interactions occurring with the intermingled tumor microenvironment (TME) by high-resolution transcriptomics...
March 26, 2024: Cancer Res Commun
https://read.qxmd.com/read/38539550/contrast-clearance-analysis-cca-to-assess-viable-tumour-following-stereotactic-radiosurgery-srs-to-brain-metastasis-in-non-small-cell-lung-cancer-nsclc
#25
JOURNAL ARTICLE
Shybi Mohamedkhan, Sumeet Hindocha, James de Boisanger, Thomas Millard, Liam Welsh, Philip Rich, Andrew D MacKinnon, Nicholas Williams, Bhupinder Sharma, Nicola Rosenfelder, Anna Minchom
BACKGROUND AND OBJECTIVE: Brain metastases are common in lung cancer and increasingly treated using targeted radiotherapy techniques such as stereotactic radiosurgery (SRS). Using MRI, post-SRS changes may be difficult to distinguish from progressive brain metastasis. Contrast clearance analysis (CCA) uses T1-weighted MRI images to assess the clearance of gadolinium and can be thus used to assess vascularity and active tumours. DESIGN AND METHODS: We retrospectively assessed CCAs in 62 patients with non-small cell lung cancer (NSCLC) undergoing 104 CCA scans in a single centre...
March 20, 2024: Cancers
https://read.qxmd.com/read/38539544/clinical-workflow-of-cone-beam-computer-tomography-based-daily-online-adaptive-radiotherapy-with-offline-magnetic-resonance-guidance-the-modular-adaptive-radiotherapy-system-mars
#26
JOURNAL ARTICLE
Ji-Young Kim, Bouchra Tawk, Maximilian Knoll, Philipp Hoegen-Saßmannshausen, Jakob Liermann, Peter E Huber, Mona Lifferth, Clemens Lang, Peter Häring, Regula Gnirs, Oliver Jäkel, Heinz-Peter Schlemmer, Jürgen Debus, Juliane Hörner-Rieber, Fabian Weykamp
PURPOSE: The Ethos (Varian Medical Systems) radiotherapy device combines semi-automated anatomy detection and plan generation for cone beam computer tomography (CBCT)-based daily online adaptive radiotherapy (oART). However, CBCT offers less soft tissue contrast than magnetic resonance imaging (MRI). This work aims to present the clinical workflow of CBCT-based oART with shuttle-based offline MR guidance. METHODS: From February to November 2023, 31 patients underwent radiotherapy on the Ethos (Varian, Palo Alto, CA, USA) system with machine learning (ML)-supported daily oART...
March 19, 2024: Cancers
https://read.qxmd.com/read/38532729/serplulimab-monotherapy-in-extensive-stage%C3%A2-small-cell-lung-cancer-with-brain-metastasis-a-case-report
#27
JOURNAL ARTICLE
Xudong Xiang, Heng Li, Bao Lei, Benchao Chen, Gaofeng Li
Small-cell lung cancer (SCLC) is an aggressive form of lung cancer with limited treatment options, especially for extensive-stage (ES) patients. We present a case of a 70-year-old male with ES-SCLC and asymptomatic brain metastasis who opted for immune monotherapy with serplulimab (an anti-PD-1 antibody). After four cycles, the patient achieved a confirmed partial response and a progression-free survival of over 1 year. Moreover, we observed a consistent decline in tumor biomarkers, and brain MRI indicated reduced metastatic activity...
March 27, 2024: Immunotherapy
https://read.qxmd.com/read/38529651/prediction-of-lymphovascular-space-invision-in-endometrial-cancer-based-on-multi-parameter-mri-radiomics-model
#28
JOURNAL ARTICLE
Jin Jun Wang, Xiao Hong Zhang, Xing Hua Guo, Yang Ying, Xiang Wang, Zhong Hua Luan, Wei Qin Lv, Peng Fei Wang
UNLABELLED: <p>Objective: To explore the application value of a combined model based on multi-parameter MRI radiomics and clinical features in preoperative prediction of lymphatic vascular space invasion (LVSI) in endometrial carcinoma (EC). METHODS: This retrospective study collected the clinicopathological and imaging data of 218 patients with EC in Yuncheng Central Hospital from March 2018 to May 2022. The patients were randomly divided into training group (n=152) and validation group (n= 66) according to the ratio of 7: 3...
March 19, 2024: Current medical imaging
https://read.qxmd.com/read/38523724/a-rare-case-of-non-small-cell-lung-cancer-presenting-as-exudative-retinal-detachment
#29
JOURNAL ARTICLE
Raphaëlle Dermine, Pierre-Antoine Poncelet, Vincent Verschaeve
Teaching Point: Retinal detachment is a rare initial clinical manifestation of lung cancer with intraorbital metastases, early diagnosis on magnetic resonance imaging is important for therapeutic implications.
2024: Journal of the Belgian Society of Radiology
https://read.qxmd.com/read/38515206/correction-deep-learning-based-metastasis-detection-in-patients-with-lung-cancer-to-enhance-reproducibility-and-reduce-workload-in-brain-metastasis-screening-with-mri-a-multi-center-study
#30
Yae Won Park, Ji Eun Park, Sung Soo Ahn, Kyunghwa Han, NakYoung Kim, Joo Young Oh, Da Hyun Lee, So Yeon Won, Ilah Shin, Ho Sung Kim, Seung-Koo Lee
No abstract text is available yet for this article.
March 21, 2024: Cancer Imaging: the Official Publication of the International Cancer Imaging Society
https://read.qxmd.com/read/38515096/clinical-characteristics-and-mri-based-radiomics-nomograms-can-predict-ipfs-and-short-term-efficacy-of-third-generation-egfr-tki-in-egfr-mutated-lung-adenocarcinoma-with-brain-metastases
#31
JOURNAL ARTICLE
Haoran Qi, Yichen Hou, Zhonghang Zheng, Mei Zheng, Qiang Qiao, Zihao Wang, Xiaorong Sun, Ligang Xing
BACKGROUND: Predicting short-term efficacy and intracranial progression-free survival (iPFS) in epidermal growth factor receptor gene mutated (EGFR-mutated) lung adenocarcinoma patients with brain metastases who receive third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy was of great significance for individualized treatment. We aimed to construct and validate nomograms based on clinical characteristics and magnetic resonance imaging (MRI) radiomics for predicting short-term efficacy and intracranial progression free survival (iPFS) of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma patients with brain metastases...
March 21, 2024: BMC Cancer
https://read.qxmd.com/read/38511680/effective-and-safe-treatment-of-risky-localized-liver-tumors-using-microwave-ablation-in-patients-with-comorbid-lung-diseases-unfit-for-deep-anesthesia
#32
JOURNAL ARTICLE
Murat Asik
OBJECTIVE: To assess the safety and efficacy of percutaneous microwave ablation (MWA) in treating high-risk localized liver tumors in patients unable to undergo deep anesthesia because of comorbid lung diseases. METHODS: Between January 2019 and January 2022, percutaneous MWA procedures were performed for 50 liver tumors. These lesions were situated in close proximity to anatomically essential structures, with a maximum distance to surrounding structures being 10 mm...
March 21, 2024: Medeniyet medical journal
https://read.qxmd.com/read/38508719/prevalence-of-lung-cysts-in-adolescents-and-adults-with-a-germline-dicer1-pathogenic-likely-pathogenic-variant-a-report-from-the-national-institutes-of-health-and-international-pleuropulmonary-blastoma-dicer1-registry
#33
JOURNAL ARTICLE
Alexander T Nelson, Lauren M Vasta, Dave Watson, Jung Kim, Anne K Harris, Ana F Best, Laura A Harney, Ann G Carr, Nicole Frederickson, Louis P Dehner, Christian P Kratz, Kelly N Hagedorn, William A Mize, Alexander Ling, Yoav H Messinger, D Ashley Hill, Kris Ann P Schultz, Douglas R Stewart
BACKGROUND: Pleuropulmonary blastoma (PPB), the hallmark tumour associated with DICER1 -related tumour predisposition, is characterised by an age-related progression from a cystic lesion (type I) to a high-grade sarcoma with mixed cystic and solid features (type II) or purely solid lesion (type III). Not all cystic PPBs progress; type Ir (regressed), hypothesised to represent regressed or non-progressed type I PPB, is an air-filled, cystic lesion lacking a primitive sarcomatous component...
March 20, 2024: Thorax
https://read.qxmd.com/read/38503918/expect-the-unexpected-investigating-discordant-prostate-mri-and-biopsy-results
#34
JOURNAL ARTICLE
Arnaldo Stanzione, Kang-Lung Lee, Nimalan Sanmugalingam, Ishwariya Rajendran, Nikita Sushentsev, Iztok Caglič, Tristan Barrett
OBJECTIVES: To evaluate discrepant radio-pathological outcomes in biopsy-naïve patients undergoing prostate MRI and to provide insights into the underlying causes. MATERIALS AND METHODS: A retrospective analysis was conducted on 2780 biopsy-naïve patients undergoing prostate MRI at a tertiary referral centre between October 2015 and June 2022. Exclusion criteria were biopsy not performed, indeterminate MRI findings (PI-RADS 3), and clinically insignificant PCa (Gleason score 3 + 3)...
March 20, 2024: European Radiology
https://read.qxmd.com/read/38498926/improved-prediction-of-epidermal-growth-factor-receptor-status-by-combined-radiomics-of-primary-nonsmall-cell-lung-cancer-and-distant-metastasis
#35
JOURNAL ARTICLE
Yue Hu, Yikang Geng, Huan Wang, Huanhuan Chen, Zekun Wang, Langyuan Fu, Bo Huang, Wenyan Jiang
OBJECTIVES: This study aimed to investigate radiomics based on primary nonsmall-cell lung cancer (NSCLC) and distant metastases to predict epidermal growth factor receptor (EGFR) mutation status. METHODS: A total of 290 patients (mean age, 58.21 ± 9.28) diagnosed with brain (BM, n = 150) or spinal bone metastasis (SM, n = 140) from primary NSCLC were enrolled as a primary cohort. An external validation cohort, consisting of 69 patients (mean age, 59.87 ± 7...
March 18, 2024: Journal of Computer Assisted Tomography
https://read.qxmd.com/read/38496696/imaging-performance-of-thoracic-smarca4-deficient-undifferentiated-tumor-a-case-report-and-literature-review
#36
Di Yang, Yong Wang
BACKGROUND: SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is a class of high-grade malignant tumors that has only been described in recent years, with an undifferentiated or rhabdoid morphology and genetic deletion of SMARCA4 ( BRG1 ), a subunit of the BRG1 -associated factors (BAFs) chromatin remodeling complex. It is a rare tumor type that occurs in young to middle-aged men and usually presents as a compressive thoracic mass with rapid progression and poor prognosis. However, much remains unknown about the clinical and imaging manifestations of the disease...
February 29, 2024: Translational Lung Cancer Research
https://read.qxmd.com/read/38494277/paraneoplastic-autoimmune-myelopathies
#37
REVIEW
Mayra Montalvo, Eoin P Flanagan
Paraneoplastic myelopathies are a rare but important category of myelopathy. They usually present with an insidious or subacute progressive neurologic syndrome. Risk factors include tobacco use and family history of cancer. Cerebrospinal fluid analysis usually shows lymphocytic pleocytosis with elevated protein. MRI findings suggest that paraneoplastic myelopathies include longitudinally extensive T2 hyperintensities that are tract-specific and accompanied by enhancement, but spinal MRIs can also be normal...
2024: Handbook of Clinical Neurology
https://read.qxmd.com/read/38466886/surgery-of-enlarging-lesions-after-stereotactic-radiosurgery-for-brain-metastases-in-patients-with-non-small-cell-lung-cancer-with-oncogenic-driver-mutations-frequently-reveals-radiation-necrosis-case-series-and-review
#38
REVIEW
Fang Zhou, Leilei Jiang, Xuankai Sun, Zhen Wang, Jialin Feng, Ming Liu, Zhao Ma
In brain metastases, radiation necrosis (RN) is a complication that arises after single or multiple fractionated stereotactic radiosurgery (SRS/FSRS), which is challenging to distinguish from local recurrence (LR). Studies have shown increased RN incidence rates in non-small cell lung cancer (NSCLC) patients with oncogenic driver mutations (ODMs) or receiving tyrosine kinase inhibitors (TKIs). This study investigated enlarging brain lesions following SRS/FSRS, for which additional surgeries were performed to distinguish between RN and LR...
March 11, 2024: APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica
https://read.qxmd.com/read/38457839/equivalent-uniform-aerobic-dose-in-radiotherapy-for-hypoxic-tumors
#39
JOURNAL ARTICLE
Alexei V Chvetsov, Mark Muzi
Equivalent uniform aerobic dose (EUAD) is proposed for comparison of integrated cell survival in tumors with different distributions of hypoxia and radiation dose. The EUAD assumes that for any non-uniform distributions of radiation dose and oxygen enhancement ratio (OER) within a tumor, there is a uniform distribution of radiation dose under hypothetical aerobic conditions with OER=1 that produces equal integrated survival of clonogenic cells. This definition of EUAD has several advantages. First, the EUAD allows one to compare survival of clonogenic cells in tumors with intra-tumor and inter-tumor variation of radio sensitivity due to hypoxia because the cell survival is recomputed under the same benchmark oxygen level (OER=1)...
March 8, 2024: Physics in Medicine and Biology
https://read.qxmd.com/read/38457550/a-case-of-empty-sella-syndrome-with-adrenal-insufficiency-masked-by-prednisolone-after-administration-of-immune-checkpoint-inhibitors
#40
JOURNAL ARTICLE
Yuichiro Iwamoto, Fuminori Tatsumi, Mana Ohnishi, Yukino Katakura, Tomohiko Kimura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Hideaki Kaneto
INTRODUCTION: The use of immune checkpoint inhibitors (ICIs) is gradually increasing; ICIs produce a variety of immune-related adverse events (irAEs), especially ICI-induced hypoadrenocorticism, which can be a lethal complication if treatment is delayed. PATIENT CONCERNS: A 63-year-old man received chemotherapy with pembrolizumab for nonsmall cell lung cancer. He developed drug-induced interstitial pneumonia 366 days after receiving pembrolizumab and was treated with prednisolone...
March 8, 2024: Medicine (Baltimore)
keyword
keyword
52486
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.